Detalles de la búsqueda
1.
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma.
J Cancer Res Clin Oncol
; 140(11): 1947-56, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24942335
2.
The BCR/ABL-extra signal fluorescence in situ hybridization system reliably detects deletions upstream of the ABL locus: implications for reporting of results and followup of chronic myelogenous leukemia patients.
Cancer Genet Cytogenet
; 136(2): 149-50, 2002 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12237241
3.
Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority.
Blood
; 101(5): 1941-9, 2003 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12411298
4.
Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions.
Blood
; 102(6): 2205-12, 2003 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12750153
5.
CML with an e1a3 BCR-ABL fusion: rare, benign, and a potential diagnostic pitfall.
Blood
; 100(3): 1092-3, 2002 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12130477
Resultados
1 -
5
de 5
1
Próxima >
>>